Gene · 9133
Papers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment. | Cancers (Basel) | 2023 | 37444584 | PubTator, text mining | PubMed |
| Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma. | Altern Ther Health Med | 2023 | 37442189 | PubTator, text mining | PubMed |
| Bioinformatics analysis to identify breast cancer-related potential targets and candidate small molecule drugs. | Mutat Res | 2023 | 37437506 | PubTator, text mining | PubMed |
| Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma. | Biol Sex Differ | 2023 | 37434223 | PubTator, text mining | PubMed |
| Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies. | Indian J Ophthalmol | 2023 | 37417104 | PubTator, text mining | PubMed |
| Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma. | Genes Dis | 2023 | 37397559 | PubTator, text mining | PubMed |
| False discovery rate control in cancer biomarker selection. | Genes Dis | 2023 | 37397555 | PubTator, text mining | PubMed |
| High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma. | Front Immunol | 2023 | 37388735 | PubTator, text mining | PubMed |
| UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival. | Front Genet | 2023 | 37377594 | PubTator, text mining | PubMed |
| Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach. | Cancers (Basel) | 2023 | 37370767 | PubTator, text mining | PubMed |
Inflammasome activation and metabolic remodelling in p16-positive aging cells aggravates high-fat diet-induced lung fibrosis by inhibiting NEDD4L-mediated K48-polyubiquitin-dependent degradation of SGK1. | Clin Transl Med | 2023 | 37345264 | PubTator, text mining | PubMed |
| LncRNA landscape and associated ceRNA network in placental villus of unexplained recurrent spontaneous abortion. | Reprod Biol Endocrinol | 2023 | 37340405 | PubTator, text mining | PubMed |
| Search for key genes, key signaling pathways, and immune cell infiltration in uterine fibroids by bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37335740 | PubTator, text mining | PubMed |
| Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor. | Oncogene | 2023 | 37330596 | PubTator, text mining | PubMed |
| Key genes involved with prognosis were identified in lung adenocarcinoma by integrated bioinformatics analysis. | Heliyon | 2023 | 37313154 | PubTator, text mining | PubMed |
| The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer. | Cancer Res | 2023 | 37289025 | PubTator, text mining | PubMed |
| Exploration of the potential common pathogenic mechanisms in COVID-19 and silicosis by using bioinformatics and system biology. | Funct Integr Genomics | 2023 | 37278873 | PubTator, text mining | PubMed |
| The increased cfRNA of TNFSF4 in peripheral blood at late gestation and preterm labor: its implication as a noninvasive biomarker for premature delivery. | Front Immunol | 2023 | 37275889 | PubTator, text mining | PubMed |
| A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma. | J Clin Transl Res | 2023 | 37275579 | PubTator, text mining | PubMed |
| CD168+ macrophages promote hepatocellular carcinoma tumor stemness and progression through TOP2A/β-catenin/YAP1 axis. | iScience | 2023 | 37275516 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9133/papers?page=14